Home

Nemilosrdný chyba Soutěž overall survival metastatic renal cancer plat porazit kamaráde

Overall survival curves for (A) all 140 patients with metastatic renal... |  Download Scientific Diagram
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram

Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal  Cell Carcinoma Patients: A Population-based Study - European Urology Focus
Survival after Cytoreductive Nephrectomy in Metastatic Non-clear Cell Renal Cell Carcinoma Patients: A Population-based Study - European Urology Focus

Kaplan-Meier curve depicting the overall survival of 359 metastatic... |  Download Scientific Diagram
Kaplan-Meier curve depicting the overall survival of 359 metastatic... | Download Scientific Diagram

Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the  Surveillance Epidemiology and End Results (SEER) database: A new tool to  predict survival in surgically treated renal cell carcinoma patients
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients

Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic  Renal Cell Cancer | Anticancer Research
Efficacy and Safety of Axitinib Therapy After Nivolumab for Patients With Metastatic Renal Cell Cancer | Anticancer Research

Determinants of renal cell carcinoma invasion and metastatic competence |  Nature Communications
Determinants of renal cell carcinoma invasion and metastatic competence | Nature Communications

Individualized therapy for metastatic renal cell carcinoma
Individualized therapy for metastatic renal cell carcinoma

Cancers | Free Full-Text | Time on Therapy for at Least Three Months  Correlates with Overall Survival in Metastatic Renal Cell Carcinoma
Cancers | Free Full-Text | Time on Therapy for at Least Three Months Correlates with Overall Survival in Metastatic Renal Cell Carcinoma

Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib |  NEJM
Overall Survival in Renal-Cell Carcinoma with Pazopanib versus Sunitinib | NEJM

xmlinkhub
xmlinkhub

Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic  Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A  Propensity-Score Matching Analysis
Prognostic Impact of Bone Metastasis on Survival Outcomes in Patients with Metastatic Renal Cell Carcinoma Treated by First Line Tyrosine Kinase Inhibitors: A Propensity-Score Matching Analysis

Real-world outcomes in patients with metastatic renal cell carcinoma  according to risk factors: the STAR-TOR registry | Future Oncology
Real-world outcomes in patients with metastatic renal cell carcinoma according to risk factors: the STAR-TOR registry | Future Oncology

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma | NEJM
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma | NEJM

Cureus | Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine  Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell  Carcinoma? | Article
Cureus | Sunitinib or Pazopanib: Is There Any Difference Between Tyrosine Kinase Inhibitors in the Pre-Nivolumab Setting in Metastatic Renal Cell Carcinoma? | Article

Management of poor-risk metastatic renal cell carcinoma: current  approaches, the role of temsirolimus and future directions | Future Oncology
Management of poor-risk metastatic renal cell carcinoma: current approaches, the role of temsirolimus and future directions | Future Oncology

Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma
Frontiers | Causes of Death and Conditional Survival of Renal Cell Carcinoma

Safety and efficacy of nivolumab in combination with sunitinib or pazopanib  in advanced or metastatic renal cell carcinoma: the CheckMate 016 study |  Journal for ImmunoTherapy of Cancer | Full Text
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study | Journal for ImmunoTherapy of Cancer | Full Text

Changes in therapy and survival of metastatic renal cell carcinoma in  Estonia | BMC Cancer | Full Text
Changes in therapy and survival of metastatic renal cell carcinoma in Estonia | BMC Cancer | Full Text

Overall survival for patients with progressive metastatic renal cell... |  Download Scientific Diagram
Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram

Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously  Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences  and Prognostic Factors
Cancers | Free Full-Text | Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download  Scientific Diagram
Kaplan–Meier curves depicting overall survival (OS; a, b) and... | Download Scientific Diagram

Comprehensive review of chromophobe renal cell carcinoma - ScienceDirect
Comprehensive review of chromophobe renal cell carcinoma - ScienceDirect

Frontiers | Metastatic Renal Cell Carcinoma Management: From Molecular  Mechanism to Clinical Practice
Frontiers | Metastatic Renal Cell Carcinoma Management: From Molecular Mechanism to Clinical Practice

Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated  With Sunitinib With or Without Cryoablation
Frontiers | Survival in Metastatic Renal Cell Carcinoma Patients Treated With Sunitinib With or Without Cryoablation

Five-year overall survival curves of renal cell carcinoma patients... |  Download Scientific Diagram
Five-year overall survival curves of renal cell carcinoma patients... | Download Scientific Diagram